XLO - Xilio Therapeutics Inc (Healthcare: Biotechnology) Projected Earnings Date: 0000-02-29    (Delayed quote data   2025-07-11)
Last
 0.73		 Change
 ⇓ -0.01   (0.00%)		 Volume
  259,123
Open
 0.74		 High
 0.74		 Low
 0.71
8EMA (Daily)
 0.71		 40EMA (Daily)
 0.73		 50EMA (Daily)
 0.74		 STO (Daily)
 91.778		 MACD Hist (Daily)
 0.020
8EMA (Weekly)
 0.736		 40EMA (Weekly)
 0.86		 50EMA (Weekly)
 0.91		 STO (Weekly)
 12.857		 MACD Hist (Weekly)
 -0.008
Company Profile
Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com